333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma

Santosh Kesari, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Xiao-Tang Kong, Frank Hsu, Jose Carrillo, Mehrdad Abedi, Robert Aiken, Thomas Taylor, Aleksandra Poole, Candace Hsieh, Gabriel Nistor, Robert Dillman

Open source

DOI: 10.1136/jitc-2021-sitc2021.333
Published: 2021-11
Container: Regular and Young Investigator Award Abstracts
Publisher: BMJ Publishing Group Ltd
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2021-sitc2021.333,
  title = {333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma},
  author = {Santosh Kesari and Daniela Bota and David Piccioni and Christopher Duma and Renato LaRocca and Xiao-Tang Kong and Frank Hsu and Jose Carrillo and Mehrdad Abedi and Robert Aiken and Thomas Taylor and Aleksandra Poole and Candace Hsieh and Gabriel Nistor and Robert Dillman},
  year = {2021},
  journal = {Regular and Young Investigator Award Abstracts},
  doi = {10.1136/jitc-2021-sitc2021.333},
  url = {https://doi.org/10.1136/jitc-2021-sitc2021.333}
}

RIS

TY  - JOUR
TI  - 333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma
AU  - Santosh Kesari
AU  - Daniela Bota
AU  - David Piccioni
AU  - Christopher Duma
AU  - Renato LaRocca
AU  - Xiao-Tang Kong
AU  - Frank Hsu
AU  - Jose Carrillo
AU  - Mehrdad Abedi
AU  - Robert Aiken
AU  - Thomas Taylor
AU  - Aleksandra Poole
AU  - Candace Hsieh
AU  - Gabriel Nistor
AU  - Robert Dillman
PY  - 2021
JO  - Regular and Young Investigator Award Abstracts
DO  - 10.1136/jitc-2021-sitc2021.333
UR  - https://doi.org/10.1136/jitc-2021-sitc2021.333
ER  -

APA

Kesari, S., Bota, D., Piccioni, D., Duma, C., LaRocca, R., Kong, X., Hsu, F., Carrillo, J., Abedi, M., Aiken, R., Taylor, T., Poole, A., Hsieh, C., Nistor, G., & Dillman, R. (2021). 333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2021-sitc2021.333

Source records

crossref · retrieved 2026-09-26T17:15:26.488Z